Rewards: See Rewards Program Terms at carecredit.com/rewardsterms for details
van Gennip, A., van Lenthe, H., Abeling, N., Bakker, H
Why GLP-1 Medications Are Prescribed GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide are approved for: Adults with a body mass index (BMI) of 30 or greater Adults with a BMI of 27 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or high cholesterol These medications mimic the GLP-1 hormone, which helps regulate appetite, glucose levels, and insulin secretion
Our recommended Wegovy starting doses are as follows: If you have previously experienced difficulties with Mounjaro side effects, our clinicians may recommend that you begin on a lower strength of Wegovy than whats listed above
with commentary from two of Communes resident female biohackers Schuyler Grant and Cooper Moll
For obesity in particular, these medicines clearly work but are expensive, and it is illogical to say that we try to fix our obesity crisis with medicines taken indefinitely to supress ones appetite, without tackling the social, financial and environmental aspects that are driving obesity in the first place